Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03259828
Other study ID # A-BR-106-037
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 6, 2017
Est. completion date December 31, 2020

Study information

Verified date February 2021
Source National Cheng-Kung University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Radiotherapy is used in cancer treatment to eradicate microscopic cancer cells to lower the risk of recurrence. The radiotherapy plan must account for organ movement inside the body to ascertain adequate dose is delivered to the target. Knowledge of the magnitude is crucial to radiotherapy treatment planning. This study aims to quantify the movement of the sigmoid colon between different fractions of radiotherapy treatment (interfraction motion) and within the same fraction (intrafraction motion). This knowledge will help us determine the optimal margin to use in radiotherapy treatment planning.


Description:

Day-to-day positioning variations contribute to uncertainty in radiotherapy. The International Commission on Radiation Units and Measurements (ICRU) report 62 recommended a margin added to the clinical target volume (CTV) to produce the planning target volume (PTV). In ICRU report 83, this concept is further extended and refined to yield the internal target volume (ITV), which is defined as CTV plus a margin to account for uncertainty within the patient. Image-guided radiotherapy (IGRT) has been developed as a method to lower the margin required in PTV expansion. In current practice, IGRT methods mostly rely on bony anatomy alignment. Due to its nature, internal organ motion cannot be compensated by IGRT. Therefore, an ITV expansion is still required. The optimal ITV expansion margin depends on the magnitude of internal organ motion; the smallest margin that provides adequate coverage is preferred. In this study, we aim to quantify organ motion of the sigmoid colon anastomosis site during radiotherapy treatment, including movement between fractions (interfraction) and movement within the same fraction (intrafraction).


Recruitment information / eligibility

Status Completed
Enrollment 4
Est. completion date December 31, 2020
Est. primary completion date December 31, 2020
Accepts healthy volunteers No
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria: - Patients with pathologically confirmed sigmoid colon cancer, who have received surgical excision (AR or LAR). - Anastomosis of the colon must be performed with a surgical stapler, with the staple visible on CT imaging. Exclusion Criteria: - Gross recurrent disease (defined as visible mass on CT imaging) in the pelvis. - Other malignancy within the pelvic cavity. - Previous surgery to the pelvic cavity other than AR/LAR. - Pregnant or lactating females. - Subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures.

Study Design


Intervention

Radiation:
Adjuvant image-guided radiotherapy
Image-guided adjuvant radiotherapy to the sigmoid colon surgical tumor bed and pelvic regional lymph nodes: 45-50.4 Gy in 1.8 Gy/fraction

Locations

Country Name City State
Taiwan National Cheng Kung University Hospital Tainan

Sponsors (1)

Lead Sponsor Collaborator
National Cheng-Kung University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Interfraction sigmoid colon organ motion Offset of the sigmoid colon staple site in three axes (anterior-posterior, lateral, and cranial-caudal) compared to simulation CT 90 days
Secondary Intrafraction sigmoid colon organ motion Offset of the sigmoid colon staple site in three axes (anterior-posterior, lateral, and cranial-caudal) between pre-treatment cone beam computed tomography (CBCT) and post-treatment CBCT 90 days
Secondary Setup errors Offset of couch (set-up error) when matching the pre-treatment CBCT with simulation CT 90 days
See also
  Status Clinical Trial Phase
Completed NCT03083951 - Complete Mesocolon Excision vs Locoregional Lymphadenectomy in Sigmoid Colon Cancer (CMELL) N/A
Completed NCT03390517 - A Study of Perfusion of Colorectal Anastomosis Using FLuorescence AnGiography (FLAG-trial) N/A
Not yet recruiting NCT06396806 - A Prospective, Randomized, Open, Parallel-controlled, Superior-efficacy Clinical Study of Radical Sigmoidectomy for Sigmoid Cancer Versus Radical Sigmoidectomy Combined With Indocyanine Green Fluorescence Imaging Lymphatic Tracing Dissection in the Treatment of Sigmoid Cancer N/A
Completed NCT04744792 - QoL of Colorectal Cancer Patients and Spouses
Recruiting NCT04729283 - Comparison of Quality of Life and Functionnal Resultats After Sigmodectomy Between Diverticulitis and Cancer